These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30046212)

  • 1. An Epidemiological Study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis during 2010-2015 at Shahid Faghihi Hospital, Shiraz, Iran.
    Talebi R; Saki N; Raeisi Shahraki H; Owji SH
    Iran J Med Sci; 2018 Jul; 43(4):421-425. PubMed ID: 30046212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxic epidermal necrolysis and Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in pediatric patients with a focus on newer antiepileptic drugs: A 25-year retrospective study at a single tertiary care center.
    Gleghorn KL; Voigt C; Kelly B
    Pediatr Dermatol; 2021 Jul; 38(4):812-818. PubMed ID: 34060145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine Emerging as a Driver of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An 8-Year Retrospective Study.
    Glahn JZ; Almeida MN; Kochen A; Noel O; Stogner V; Hsia HC; Savetamal A
    Burns; 2024 Nov; 50(8):2114-2123. PubMed ID: 39127578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital.
    Techasatian L; Panombualert S; Uppala R; Jetsrisuparb C
    World J Pediatr; 2017 Jun; 13(3):255-260. PubMed ID: 27650525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causative Drugs and Clinical Outcome in Stevens Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and SJS-TEN Overlap in Children.
    Sethuraman G; Sharma VK; Pahwa P; Khetan P
    Indian J Dermatol; 2012 May; 57(3):199-200. PubMed ID: 22707771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Compilation of Drug Etiologies of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Abulatan IT; Ben-David SG; Morales-Colon LA; Beason E; Fakoya AO
    Cureus; 2023 Nov; 15(11):e48728. PubMed ID: 38094551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.
    Tan SK; Tay YK
    Acta Derm Venereol; 2012 Jan; 92(1):62-6. PubMed ID: 21710108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study.
    Barvaliya M; Sanmukhani J; Patel T; Paliwal N; Shah H; Tripathi C
    J Postgrad Med; 2011; 57(2):115-9. PubMed ID: 21654132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stevens-Johnson syndrome and toxic epidermal necrolysis in Dr. Hasan Sadikin General Hospital Bandung, Indonesia from 2009-2013.
    Suwarsa O; Yuwita W; Dharmadji HP; Sutedja E
    Asia Pac Allergy; 2016 Jan; 6(1):43-7. PubMed ID: 26844219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiepileptic combination therapy with Stevens-Johnson syndrome and toxic epidermal necrolysis: Analysis of a Japanese pharmacovigilance database.
    Noguchi Y; Takaoka M; Hayashi T; Tachi T; Teramachi H
    Epilepsia; 2020 Sep; 61(9):1979-1989. PubMed ID: 32761907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China.
    Yang SC; Hu S; Zhang SZ; Huang JW; Zhang J; Ji C; Cheng B
    J Immunol Res; 2018; 2018():4320195. PubMed ID: 29607330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stevens Johnson syndrome, toxic epidermal necrolysis and SJS-TEN overlap: a retrospective study of causative drugs and clinical outcome.
    Sharma VK; Sethuraman G; Minz A
    Indian J Dermatol Venereol Leprol; 2008; 74(3):238-40. PubMed ID: 18583791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 10-year retrospective cohort study of the management of toxic epidermal necrolysis and Stevens-Johnson syndrome in a New South Wales state referral hospital from 2006 to 2016.
    Chan L; Cook DK
    Int J Dermatol; 2019 Oct; 58(10):1141-1147. PubMed ID: 30908601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and treatment outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Chantaphakul H; Sanon T; Klaewsongkram J
    Exp Ther Med; 2015 Aug; 10(2):519-524. PubMed ID: 26622347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe cutaneous adverse drug reactions: Incidence, clinical patterns, causative drugs and modalities of treatment in Assiut University Hospital, Upper Egypt.
    Abou-Taleb DAE; El-Sayed AM; Ghabesha AA; Hassan SB
    Dermatol Ther; 2020 Nov; 33(6):e14176. PubMed ID: 32779328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results.
    Papp A; Sikora S; Evans M; Song D; Kirchhof M; Miliszewski M; Dutz J
    Burns; 2018 Jun; 44(4):807-815. PubMed ID: 29627131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations.
    Teraki Y; Shibuya M; Izaki S
    Clin Exp Dermatol; 2010 Oct; 35(7):723-8. PubMed ID: 19874350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis of stevens-johnson syndrome and toxic epidermal necrolysis over a period of 10 years.
    Sanmarkan AD; Sori T; Thappa DM; Jaisankar TJ
    Indian J Dermatol; 2011 Jan; 56(1):25-9. PubMed ID: 21572786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry.
    Diphoorn J; Cazzaniga S; Gamba C; Schroeder J; Citterio A; Rivolta AL; Vighi GD; Naldi L;
    Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):196-203. PubMed ID: 26687641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of culprit drugs associated with patients admitted to the burn unit with the diagnosis of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Syndrome.
    de Bustros P; Baldea A; Sanford A; Joyce C; Adams W; Bouchard C
    Burns; 2022 Nov; 48(7):1561-1573. PubMed ID: 34924230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.